cardiology

03.03.2023 • News

Victrex Expands Medical Device Capabilities

Invibio Material Solutions, the medical business of UK high-performance polymer producer Victrex, has opened a new product development facility in Leeds in order to accelerate commercialization of future applications.

13.12.2017 • News

Bayer Combines Pharma R&D in one Unit

04.01.2016 • News

Ackman Trims Valeant Stake to Create Tax Benefits

Top-Feature

Evonik Operations GmbH (Hanau)

Biobased Feedstocks as a Roadmap to Defossilization

Bio-Rad Laboratories

Dual‑Targeting Breakthroughs: Advancements in Bispecific Antibody Development

Interview

Strategic Response to a Shifting Pharma Landscape

Stability in Motion

Stefan Oelrich, Member of the Board of Management and President Pharmaceuticals, Bayer, discusses navigating external volatility, reshaping its internal structures, and investing in future-ready capabilities to ensure sustainable growth.